Genetic control of ductal morphology, estrogen-induced ductal growth, and gene expression in female mouse mammary gland

Endocrinology

Volumn 155, Issue 8, 2014, Pages 3025-3035

  Wall, Emma H ^a   Case, Laure K ^a   Hewitt, Sylvia C ^b   Nguyen Vu, Trang ^c   Candelaria, Nicholes R ^c   Teuscher, Cory ^a   Lin, Chin Yo ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; EPITHELIAL CELLS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOTYPE; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C3H; SEXUAL MATURATION; UTERUS;

EID: 84905001685     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1910     Document Type: Article

References (61)

1. Prossnitz ER, Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol. 2009; 308:32-38.
2. Dutertre M, Smith CL. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther. 2000; 295:431-437.
3. Clark JH, Mani SK. 1994. Actions of ovarian steroid hormones. In: E Knobil, J Neill, eds. The Physiology of Reproduction. New York: Raven Press; 1011-1059.
4. Hovey RC, Trott JF. Morphogenesis of mammary gland development. Adv Exp Med Biol. 2004; 554:219-228.
5. Silberstein GB. Postnatal mammary gland morphogenesis. Microsc Res Tech. 2001; 52:155-162.
6. Korach KS, Couse JF, Curtis SW, et al. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res. 1996; 51:159-186; discussion 186-158
7. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progesto-gens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993; 15:17-35.
8. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993; 15:48-65.
9. Hellberg D. Sex steroids and cervical cancer. Anticancer Res. 2012; 32:3045-3054.
10. Wang Y, van der Zee M, Fodde R, Blok LJ. Wnt/Beta-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget. 2010; 1:674-684.
11. Drasher ML. Strain differences in the response of the mouse uterus to estrogens. J Hered. 1952; 46:190-192.
12. Silberberg M, Silberberg R. Susceptibility to estrogen of breast, vagina, and endometrium of various strains of mice. Proc Soc Exp Biol Med. 1951; 76:161-164.
13. Trentin JJ. Vaginal sensitivity to estrogen as related to mammary tumor incidence in mice. Cancer Res. 1950; 10:580-583.
14. Blair SM, Blair PB, Daane TA. Differences in the mammary response to estrone and progesterone in castrate male mice of several strains and hybrids. Endocrinology. 1951; 61:643-651.
15. Griffith JS, Jensen SM, Lunceford JK, et al. Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes. Am J Pathol. 1997; 150:2223-2230.
16. Roper RJ, Griffith JS, Lyttle CR, et al. Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses. Endocrinology. 1999; 140:556-561.
17. Wall EH, Hewitt SC, Liu L, et al. Genetic control of estrogen-regulated transcriptional and cellular responses in mouse uterus. FASEB J. 2013; 27:1874-1886.
18. Schaffer BS, Lachel CM, Pennington KL, et al. Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway x ACI intercross. Cancer Res. 2006; 66:7793-7800.
19. Singh DV, DeOme KB, Bern HA. Strain differences in response of the mouse mammary gland to hormones in vitro. J Natl Cancer Inst. 1970; 45:657-675.
20. Shimkin MB, Wyman RS. Mammary tumors in malemiceimplanted with estrogen-cholesterol pellets. J Natl Cancer Inst. 1946; 7:71-75.
21. Shimkin MB, Wyman RS. Effect of adrenalectomy and ovariectomy on mammary carcinogenesis in strain C3H mice. J Natl Cancer Inst. 1945; 6:187-189.
22. Shimkin MB, Andervont HB. The effect of foster nursing on the response of mice to estrogens. J Natl Cancer Inst. 1941; 1:599-605.
23. Lee AE. Proliferative responses of mouse mammary glands to 17 beta-estradiol and progesterone and modification by mouse mammary tumor virus. J Natl Cancer Inst. 1983; 71:1265-1269.
24. Mixner JP, Turner CW. Strain differences in response of mice to mammary gland stimulating hormones. Proc Soc Exp Biol Med. 1957; 95:87-89.
25. Aupperlee MD, Drolet AA, Durairaj S, Wang W, Schwartz R.C., Haslam SZ. Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. Endocrinology. 2009; 150:1485-1494.
26. Montero Girard G, Vanzulli SI, Cerliani JP, et al. Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment. Breast Cancer Res. 2007; 9:R22.
27. Spearow JL, Doemeny P, Sera R, Leffler R., Barkley M. Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science. 1999; 285:1259-1261.
28. Pashayan N, Duffy SW, Chowdhury S, et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer. 2011; 104:1656-1663.
29. Pharoah PD, Antoniou A, Bobrow M, Zimmern R.L., Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002; 31:33-36.
30. Ghoussaini M, Pharoah PD. Polygenic susceptibility to breast cancer: current state-of-the-art. Future Oncol. 2009; 5:689-701.
31. Hewitt SC, Bocchinfuso WP, Zhai J, et al. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu. Cancer Res. 2002; 62:2798-2805.
32. National Institute of Health. 1999. Biology of the Mammary Gland. http://mammary.nih.gov/tools/histological/Histology/index.html#a1.
33. Deroo BJ, Hewitt SC, Collins JB, Grissom S.F., Hamilton KJ, Korach KS. Profile of estrogen-responsive genes in an estrogen-specific mammarygl an dout growth model. MolReprodDev. 2009; 76:733-750.
34. Gardner WU, Strong LC. Thenormal development of the mammary glands of virgin female mice of ten strains varying in susceptibility to spontaneous neoplasms. Am J Cancer. 1935; 25:282-290.
35. Yant J, Gusterson B, Kamalati T. Induction of strain-specific mouse mammary gland ductal architecture. The Breast. 1998; 7:269-272.
36. Naylor MJ, Ormandy CJ. Mouse strain-specific patterns of mammary epithelial ductal side branching are elicited by stromal factors. Dev Dyn. 2002; 225:100-105.
37. Gould KA, Pandey J, Lachel CM, et al. Genetic mapping of Eutr1, a locus controlling E2-induced pyometritis in the Brown Norway rat, to RNO5. Mamm Genome. 2005; 16:854-864.
38. Jordan VC, Gottardis MM, Satyaswaroop PG. Tamoxifen-stimu-lated growth of human endometrial carcinoma. Ann N Y Acad Sci. 1991; 622:439-446.
39. Norgaard JV, Theil PK, Sorensen MT, Sejrsen K. Cellular mechanisms in regulating mammary cell turnover during lactation and dry period in dairy cows. J Dairy Sci. 2008; 91:2319-2327.
40. Gregoraszczuk E, Ptak A. Involvement of caspase-9 but not caspase-8 in the anti-apoptotic effects of estradiol and 4-OH-Estra-diol in MCF-7 human breast cancer cells. Endocr Regul. 2011; 45: 3-8.
41. Stevens TA, Meech R. BARX2 and estrogen receptor-alpha (ESR1) coordinately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion. On-cogene. 2006; 25:5426-5435.
42. Ito Y. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res. 2008; 99:33-76.
43. Doll A, Gonzalez M, Abal M, et al. An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasis. Int J Cancer. 2009; 125:257-263.
44. Planaguma J, Abal M, Gil-Moreno A, et al. Up-regulation of ERM/ ETV5 correlates with the degree of myometrial infiltration in en-dometrioid endometrial carcinoma. J Pathol. 2005; 207:422-429.
45. Stender JD, Kim K, Charn TH, et al. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated tran-scriptional activation. Mol Cell Biol. 2010; 30:3943-3955.
46. Chimge NO, Frenkel B. The RUNX family in breast cancer: relationships with estrogen signaling. Oncogene. 2013; 32:2121-2130.
47. Watson CJ, Neoh K. The Stat family of transcription factors have diverse roles in mammary gland development. Semin Cell Dev Biol. 2008; 19:401-406.
48. McBryan J, Howlin J, Napoletano S, Martin F. Amphiregulin: role in mammary gland development and breast cancer. J Mammary Gland Biol. Neoplasia. 2008; 13:159-169.
49. Pollard JW. Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res. 2001; 3:230-237.
50. Suzuki A, Urushitani H, Watanabe H., et al. Comparison ofestrogen responsive genes in the mouse uterus, vagina and mammary gland. J Vet Med Sci. 2007; 69:725-731.
51. Lu S, Becker KA, Hagen MJ, et al. Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity. Endocrinology. 2008; 49:4809-4820.
52. Calvo E, Luu-The V, Belleau P, Martel C., Labrie F. Specific tran-scriptional response of four blockers of estrogen receptors on estra-diol-modulated genes in the mouse mammary gland. Breast Cancer Res Treat. 2012; 134:625-647.
53. Bouxsein ML, Myers KS, Shultz KL, Donahue L.R., Rosen CJ, Beamer WG. Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Miner Res. 2005; 20:1085-1092.
54. Li CY, Schaffler MB, Wolde-Semait HT, Hernandez CJ, Jepsen KJ. Genetic background influences cortical bone response to ovariec-tomy. J Bone Miner Res. 2005; 20:2150-2158.
55. Simpson ER, Jones ME. Of mice and men: the many guises of estrogens. Ernst Schering Found Symp Proc. 2006; 1:45-67.
56. Altmae S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod. Update. 2011; 17:813-828.
57. Riggs BL, Khosla S, Melton LJ 3rd. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998; 13:763-773.
58. Richards JB, Zheng HF, Spector TD. Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nat Rev Genet. 2012; 13:576-588.
59. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006; 1:9.
60. Krausz C, Giachini C. Genetic risk factors in male infertility. Arch Androl. 2007; 53:125-133.
61. Loutradis D, Theofanakis C, Anagnostou E, Mavrogianni D., Partsinevelos GA. Genetic profile of SNP(s) and ovulation induction. Curr Pharm Biotechnol. 2012; 13:417-425.